ADAMTS5 and renal cell carcinoma: Understanding the regulatory interactions among LRRC75A-AS1, miR-370-5p and ADAMTS5 may provide new insights into the molecular mechanisms underlying RCC and facilitate the identification of novel therapeutic targets.